<https://rdf.molmedb.upol.cz/reference/ref925> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target47>,
		<https://rdf.molmedb.upol.cz/transporter/target46>;
	<http://purl.org/ontology/bibo/doi> "10.1021/jm00401a024"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/pmid> "2836591"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00399>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM470910>;
	<http://purl.org/dc/terms/bibliographicCitation> "Adelstein GW, Yen CH, Haack RA, Yu S, Gullikson G, Price DV, Anglin C, Decktor DL, Tsai H, Keith RH.: Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase. J Med Chem, Volume 31 (6), 1988"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/transporter/tra58833> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref925> .
<https://rdf.molmedb.upol.cz/transporter/tra57895> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref925> .
<https://rdf.molmedb.upol.cz/transporter/tra58832> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref925> .
<https://rdf.molmedb.upol.cz/transporter/tra57901> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref925> .